Novartis AG Common Stock (NVS)

Total Costs & Expenses

$9.68B

Quarterly · Period ending: · USD

NVS logo

NVS Total Costs & Expenses

Latest reported$9.68B
NVS Quarterly Total Costs & Expenses ($5.70B → $9.68B)
High-resolution chart · PNG

NVS total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
9,682,632,000
9,289,000,000
9,814,254,000
9,857,000,000
9,972,000,000
8,957,000,000
10,028,000,000
9,545,000,000
8,858,000,000
8,747,000,000
9,194,000,000
10,330,000,000
8,938,000,000
8,429,000,000
11,138,000,000
8,957,000,000
10,857,000,000
9,962,000,000
10,960,000,000
10,134,000,000
9,815,000,000
10,279,000,000
10,386,000,000
10,126,000,000
9,270,000,000
9,964,000,000
10,893,000,000
10,124,000,000
9,361,000,000
9,213,000,000
12,365,000,000
9,147,000,000
9,222,000,000
8,792,000,000
11,094,000,000
10,335,000,000
10,214,000,000
9,863,000,000
11,151,000,000
10,072,000,000
10,586,000,000
9,359,000,000
11,127,000,000
10,251,000,000
10,615,000,000
9,417,000,000
11,003,000,000
10,561,000,000
10,765,000,000
10,216,000,000
12,990,000,000
10,348,000,000
10,247,000,000
11,310,000,000
12,587,000,000
11,091,000,000
11,433,000,000
11,177,000,000
13,679,000,000
12,083,000,000
11,801,000,000
10,814,000,000
11,997,000,000
10,233,000,000
8,960,000,000
8,845,000,000
10,508,000,000
8,656,000,000
8,378,000,000
7,579,000,000
8,668,000,000
8,695,000,000
8,529,000,000
7,728,000,000
9,864,000,000
7,776,000,000
7,171,000,000
7,039,000,000
7,720,000,000
7,045,000,000
6,280,000,000
6,092,000,000
7,265,000,000
6,601,000,000
6,021,000,000
5,661,000,000
6,044,000,000
5,340,000,000
5,179,000,000
5,145,000,000
5,124,000,000
4,741,000,000
4,740,000,000
4,370,000,000
5,917,000,000
3,817,000,000
4,156,000,000
4,858,000,000
5,138,000,000
5,576,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.